QQ客服 官方微博 反馈留言

	Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer
	Laber, Damian A.[1]; Chen, Min-Bin[2]; Jaglal, Michael[3]; Patel, Ankita[4]; Visweshwar, Nathan[5]
刊名	CLINICAL GENITOURINARY CANCER
	2018
卷号	16期号:6页码:473-481
关键词	Cabazitaxel Chemotherapy Docetaxel Phase 2 clinical trial Taxanes
ISSN号	1558-7673
DOI	http://dx.doi.org/10.1016/j.clgc.2018.06.007
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000452549600029
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5334182
专题	江苏大学
作者单位	1.[1]H Lee Moffitt Canc Ctr & Res Inst, Sect Satellite Oncol, Tampa, FL USA. 2.Univ S Florida, Morsani Sch Med, Div Hematol Oncol, Tampa, FL USA. 3.[2]Jiangsu Univ, Dept Oncol, Kunshan Peoples Hosp 1, Kunshan, Jiangsu, Peoples R China. 4.[3]H Lee Moffitt Canc Ctr & Res Inst, Sect Satellite Oncol, Tampa, FL USA. 5.Univ S Florida, Morsani Sch Med, Div Hematol Oncol, Tampa, FL USA. 6.[4]H Lee Moffitt Canc Ctr & Res Inst, Sect Satellite Oncol, Tampa, FL USA. 7.Univ S Florida, Morsani Sch Med, Div Hematol Oncol, Tampa, FL USA. 8.[5]Univ S Florida, Morsani Sch Med, Div Hematol Oncol, Tampa, FL USA.
推荐引用方式 GB/T 7714	Laber, Damian A.[1],Chen, Min-Bin[2],Jaglal, Michael[3],et al. Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer[J]. CLINICAL GENITOURINARY CANCER,2018,16(6):473-481.
APA	Laber, Damian A.[1],Chen, Min-Bin[2],Jaglal, Michael[3],Patel, Ankita[4],&Visweshwar, Nathan[5].(2018).Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer.CLINICAL GENITOURINARY CANCER,16(6),473-481.
MLA	Laber, Damian A.[1],et al."Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer".CLINICAL GENITOURINARY CANCER 16.6(2018):473-481.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。